Replies to post #749998 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

Facts are not welcome

[DocLee]

Hi FeMike, For a long time I have accepted that NWBO are playing an unorthodox game with respect to information sharing and I have accepted that this is because of the way that those who are inimical to NWBO (such as Adam Feuerastein) twist, lie about and distort any information which management puts into the public domain. I checked what you wrote in your reply (for which I thank you) and was somewhat discomforted as to what Mrs Powers said in relation to the timing of the Company's involvement with NICE: "After the MAA, and the commercialization preparation, and those activities, we also need to go through the process of applying for approval for reimbursement [ie discussions with NICE]", the inescapable implication being that negotiations with NICE would wait until after the MAA (Market Aurhorisation Application) had been granted.

This, of course, jarred with my sentiments (in the Feb.11th posting) that "I fully expect management to be working their socks off behind the scenes to launch DCVax-L onto the medical profession and into the public gaze as soon as the MHRA gives its approval. A vital part of that scenario is that a treatment price acceptable to NICE will have already been negotiated". So discomforted was I by what you reported Mrs Powers as saying at the ASM that I sought NWBO's comments on your posting. I was directed to the NICE website and the following:

"05 March 2024 [11 months ago] Update: A meeting was held between NICE and the company in early-Februay regarding next steps for the appraisal of DCVax-L for treating glioblastoma, and more information will be available in due course. NICE will continue liaising with the company and monitoring timelines".

The following exhortation was appended: "I think what they [NICE] say matters and not rumors and innuendos. Hang in there, Dave."

Am I to accept that for the last year since the ASM nothing has happened behind the scenes to advance DCVax-L's acceptance into the NHS's Therapeutic Armamentarium? Only time will tell ... and I hope that you are wrong. But, if you have been right all along, I will hold Management to be responsible for any delay in starting NICE's processing of the application for DCVax-L to be accepted into NHS usage. This will only be ameliorated if there is good evidence that the delay resulted from a shortage of available cash due to the artificially depressed share price, in which case the more reprehensible members both in society and on this discussion board will be held responsible.

Whilst a further delay into the introduction of DCVax-L might be annoying to me because it means that my 12 year wait to see if I make a profit on my investment is further delayed, my situation pails into insignificance when compared to the 40-50 people each week in the UK who are denied a potentially life-saving treatment because the processes of licencing and financing are taking so long to complete.